| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: TECFIDERA (dimethyl fumarate, BG-12, Fumaderm) | |
| ***************************************************** | |
| #Post#: 2439-------------------------------------------------- | |
| (Abst.) Tecfidera better at preventing relapses than Aubagio | |
| By: agate Date: March 18, 2019, 12:25 pm | |
| --------------------------------------------------------- | |
| This study, published in Neurology, showed Tecfidera to be | |
| better than Aubagio at preventing relapses and less likely to be | |
| discontinued due to disease breakthrough: From PubMed, March 17, | |
| 2019--"Comparative effectiveness of teriflunomide and dimethyl | |
| fumarate: A nationwide cohort study": | |
| https://www.ncbi.nlm.nih.gov/pubmed/30877188 | |
| ***************************************************** |